CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 53 enrolled
Drug / intervention
OPIOID +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05283499
NCT05283499Phase 3Completed

Opioid Analgesic Reduction Study (OARS) - Pilot

Rutgers, The State University of New Jersey·interventional·Posted Mar 17, 2022·Updated Jun 6, 2023

In Brief

A Phase 3 clinical trial evaluating OPIOID and NON-OPIOID for Post Operative Pain. Completed, enrolled 53 participants across 5 sites.

Detailed Summary

The purpose of this study is to test protocols being developed for the conduct of a large sale multi-site clinical trial which will compare opioids to non-opioids for managing post-surgical impacted 3rd molar extraction pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedMar 17, 2022
Enrollment StartJul 6, 2020
Primary CompletionMar 12, 2021
Study CompletionMar 26, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.3 years ago

Interventions

OPIOIDdrug

Analgesic assignment

NON-OPIOIDdrug

Analgesic assignment